{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:40:53Z","timestamp":1772343653329,"version":"3.50.1"},"reference-count":38,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T00:00:00Z","timestamp":1265155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Non-steroidal anti-inflammatory drugs like ibuprofen or indomethacin are commonly prescribed drugs to induce pharmacologic closure of a patent ductus arteriosus in preterm neonates. Based on a recently published Cochrane meta-analysis, both drugs are equally effective to induce closure. Drug choice can therefore be based on differences in side effects or pharmaco-economic arguments. The current review quantifies the negative impact of either ibuprofen or indomethacin on renal function, including diuresis, glomerular filtration rate and renal tubular function. Both ibuprofen and indomethacin have a quantifiable impact on renal function. However, compared to ibuprofen, the negative impact of indomethacin is more pronounced.<\/jats:p>","DOI":"10.3390\/ph3020393","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T11:15:54Z","timestamp":1265195754000},"page":"393-405","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates"],"prefix":"10.3390","volume":"3","author":[{"given":"Karel","family":"Allegaert","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"De Hoon","sequence":"additional","affiliation":[{"name":"Center for Clinical Pharmacology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Debeer","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Gewillig","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2010,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology: drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2005.12.001","article-title":"Pharmacological research in pediatrics: from neonates to adolescents","volume":"58","author":"Rakhmanina","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1651-2227.1996.tb13942.x","article-title":"Pharmacokinetics and renal function in the preterm infant","volume":"85","year":"1996","journal-title":"Acta Paediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1179\/acb.2008.003","article-title":"Developmental pharmacology: Since neonates are not just small adults","volume":"63","author":"Allegaert","year":"2008","journal-title":"Acta Clin. Belg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00467-006-0118-2","article-title":"Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions","volume":"21","author":"Cuzzolin","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1542\/peds.96.6.1156","article-title":"Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance","volume":"96","author":"Broerse","year":"1995","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00441807","article-title":"Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age","volume":"148","author":"Grose","year":"1988","journal-title":"Eur. J. Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/BF02002914","article-title":"Serum creatinine concentration, urinary creatinine excretion and creatinine clearance during the first 9 weeks in preterm infants with a birth weight below 1500 g","volume":"155","author":"Sonntag","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/FTD.0b013e31806db3f5","article-title":"Renal drug clearance in preterm neonates: relation to prenatal growth","volume":"29","author":"Allegaert","year":"2007","journal-title":"Ther. Drug Monit."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.siny.2004.10.003","article-title":"The pharmacologic closure of the patent ductus arteriosus","volume":"10","author":"Chemtob","year":"2005","journal-title":"Semin Fetal Neonatal Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/eurheartj\/ehp128","article-title":"Premature foetal closure of the arterial duct: clinical presentations and outcome","volume":"30","author":"Gewillig","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/jmf.16.6.339.341","article-title":"Association of patent ductus arteriosus and severe hypothyroidism in term neonates: coincidence or causal ?","volume":"16","author":"Allegaert","year":"2004","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jpeds.2009.07.053","article-title":"Treatment of the patent ductus arteriosus: when, how, and for how long ?","volume":"155","author":"Noori","year":"2009","journal-title":"Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14767050903198314","article-title":"Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns","volume":"22","author":"Guimaraes","year":"2009","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"F244","DOI":"10.1136\/adc.2006.104596","article-title":"Conservative treatment for patent ductus arteriosus in the preterm","volume":"92","author":"Vanhaesebrouck","year":"2007","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/14767050903195484","article-title":"Surgical closure of PDA in low-weight premature infants","volume":"22","author":"Margaryan","year":"2009","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jpeds.2006.09.001","article-title":"Indometacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice","volume":"150","author":"Clyman","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(04)17477-1","article-title":"Prohylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"364","author":"Allegaert","year":"2004","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00431-004-1596-5","article-title":"A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus","volume":"164","author":"Thomas","year":"2005","journal-title":"Eur. J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/sper.2002.37310","article-title":"The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit","volume":"26","author":"Guignard","year":"2002","journal-title":"Semin Perinatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00228-008-0586-3","article-title":"Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus","volume":"65","author":"Antonucci","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM200009073431001","article-title":"A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus","volume":"343","author":"Smets","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00467-003-1402-z","article-title":"Indomethacin and renal impairment in neonates","volume":"19","author":"Akima","year":"2004","journal-title":"Pediatr. Nephrol."},{"key":"ref_24","first-page":"267","article-title":"Ibuprofen in very preterm infants impairs renal function for the first month of life","volume":"25","author":"Desandes","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"ref_25","first-page":"CD003481","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants","volume":"1","author":"Ohlsson","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1472-8206.2004.00314.x","article-title":"Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus","volume":"19","author":"Fanos","year":"2005","journal-title":"Fundam Clin. Pharmacol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1542\/peds.103.4.e49","article-title":"Why do newborn infants have a high plasma creatinine?","volume":"103","author":"Guignard","year":"1999","journal-title":"Pediatrics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/clpt.1985.245","article-title":"A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn","volume":"38","author":"Koren","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1358\/mf.2006.28.8.1037489","article-title":"Impact of ibuprofen administration on renal drug clearance in the first weeks of life","volume":"28","author":"Allegaert","year":"2006","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00431-006-0189-x","article-title":"Population clinical pharmacology of children: modelling covariate effects","volume":"165","author":"Anderson","year":"2006","journal-title":"Eur. J. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2125.2005.02530.x","article-title":"Limited predictability of amikacin clearance in extreme premature neonates at birth","volume":"61","author":"Allegaert","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2125.2006.02725.x","article-title":"Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance","volume":"63","author":"Anderson","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000079618","article-title":"Effects of Co-Administration of Ibuprofen-Lysine on the Pharmacokinetics of Amikacin in Preterm Infants during the First Days of Life","volume":"86","author":"Allegaert","year":"2004","journal-title":"Biol. Neonate"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/14767050903180965","article-title":"The impact of ibuprofen or indomethacin on renal drug clearance in neonates","volume":"22","author":"Allegaert","year":"2009","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03118.x","article-title":"An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study","volume":"65","author":"Hirt","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1256","DOI":"10.1542\/peds.2008-1780","article-title":"Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus","volume":"122","author":"Cherif","year":"2008","journal-title":"Pediatrics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/0091270008323752","article-title":"Population pharmacokinetic analysis of ibuprofen enantiomers in preterm newborn neonates","volume":"48","author":"Gregoire","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1203\/PDR.0b013e31817d9bb0","article-title":"Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?","volume":"64","author":"Hammerman","year":"2008","journal-title":"Pediatr. Res."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/2\/393\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:01:25Z","timestamp":1760220085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/2\/393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,3]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,2]]}},"alternative-id":["ph3020393"],"URL":"https:\/\/doi.org\/10.3390\/ph3020393","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,3]]}}}